Virginia Board of Pharmacy Staffing Concerns and Statewide Protocols Update

The Virginia Board of Pharmacy has updated its guidance on reporting pharmacy staffing concerns and has amended several statewide protocols for pharmacists. Pharmacy permit holders must review and act on staffing reports, and pharmacists can report issues directly to the board without fear of retaliation. The revised protocols cover vaccinations, tuberculosis testing, hormonal contraceptives, naloxone, influenza, and strep throat.

Massachusetts: 90-day Supply for Certain Schedule II/III Prescriptions

The Massachusetts Board of Registration in Pharmacy updated its policy to allow a 90-day supply for certain Schedule II and III prescriptions, including those for opioid use disorder treatment, non-opioid stimulants, testosterone, and implantable infusion pumps. Other Schedule II and III medications remain limited to a 30-day supply.

MA Board Adopts Rapid Microbial Methods for Sterility Testing

The Massachusetts Board of Registration in Pharmacy has adopted a new policy allowing the use of Rapid Microbial Methods (RMMs) as an alternative for sterility release testing of compounded sterile preparations (CSPs). This policy outlines requirements for licensed sterile compounding pharmacies to ensure public safety when using these advanced technologies.

Rapid Microbial Methods Sterility Testing Guidance

The Massachusetts Department of Public Health has issued guidance on the use of Rapid Microbial Methods (RMMs) for sterility testing. This document outlines acceptable approaches and considerations for implementing RMMs in pharmaceutical and medical device manufacturing.

Massachusetts Pharmacy Practice Definitions

The Massachusetts Board of Registration in Pharmacy has issued a document defining key terms related to pharmacy practice. This guidance aims to clarify terminology for pharmacists and related entities operating within the state.

Pharmacy Policy: Definitions for Automated Dispensing, Compounding, and Events

The Massachusetts Board of Registration in Pharmacy has adopted Policy 2025-02, defining key terms related to automated dispensing devices, automated pharmacy systems, pharmacy processing automation, quality-related events, and serious adverse drug events. These definitions clarify regulatory expectations for pharmacies operating in the state.

Illinois Department of Financial and Professional Regulation January 2025 Enforcement Actions

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in January 2025. Actions include the FDIC taking control of Pulaski Savings Bank, consent orders for various financial institutions, and license suspensions or cease and desist orders for unlicensed practices and professional misconduct.

IDFPR February 2025 Enforcement Actions

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in February 2025 against 30 entities. Actions include license suspensions, consent orders for violations of various acts, and settlements for late renewal payments.

Illinois IDFPR May 2025 Enforcement Actions

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in May 2025 against 21 individuals and 7 companies. Actions include license revocations, consent orders, settlements, and civil penalties for violations of various financial and professional regulations.

Illinois March 2025 Disciplinary Actions

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in March 2025. Actions include consent orders for unlicensed activity, late renewal payments, reciprocal discipline, and settlements for violations of various acts. Several professional licenses were suspended for failure to pay state income taxes or child support.